CNS Drug Delivery: Opioid Peptides and the Blood-Brain Barrier

Abstract

A BSTRACTPeptides are key regulators in cellular and intercellular physiological responses and possess enormous promise for the treatment of pathological conditions. Opioid peptide activity within the central nervous system (CNS) is of particular interest for the treatment of pain owing to the elevated potency of peptides and the centrally mediated actions of pain processes. Despite this potential, peptides have seen limited use as clinically viable drugs for the treatment of pain. Reasons for the limited use are primarily based in the physiochemical and biochemical nature of peptides. Numerous approaches have been devised in an attempt to improve peptide drug delivery to the brain, with variable results. This review describes different approaches to peptide design/modifi cation and provides examples of the value of these strategies to CNS delivery of peptide drugs. The various modes of modifi cation of therapeutic peptides may be amalgamated, creating more effi cacious " hybrid " peptides, with synergistic delivery to the CNS. The ongoing development of these strategies provides promise that peptide drugs may be useful for the treatment of pain and other neurologically-based disease states in the future.

Hematopoietic growth factors pass through the blood–brain barrier in intact rats

“…The physical barrier is composed by a complex network of endothelial cells with their tight junctions, astrocytes, pericytes, perivascular macrophages, and a basal lamina. The enzymatic barrier of the BBB consists of abundant enzymes, which are capable of metabolizing blood-borne drugs and nutrients (Witt et al, 2001(Witt et al, , 2006. The BBB is dynamically acting that permits nutrients to enter to the brain and neurotoxics and waste products to exit.…”

Factor V Activator from Daboia russelli russelli Venom Destabilizes β-Amyloid Aggregate, the Hallmark of Alzheimer Disease

“…For the treatment of neurological disorders, a drug must be able to penetrate the tight and selective blood-brain barrier (BBB), which supports the brain with high nutrient and allows the flow of small hydrophobic molecules, restricting the uptake of any microscopic objects and large or hydrophilic molecules (35). For a peptide, several factors such as size, molecular mass, flexibility, conformation, properties of constituent amino acids, and their sequence affect its ability to cross the BBB (36). Molecules having rotatable bonds and greater than 450 Da are restricted by the BBB (37).…”

Antihypertensive Peptides from Food Proteins

“…Modifications such as end changes, glycosylation, alkylation, and conformational changes to amino acids within the peptide may therefore have potential for ACE inhibitory peptides [80; 81]. These approaches have already been adapted to opioid peptides [81]. There is significant scope for these modifications to also be applied to ACE inhibitory and antihypertensive peptides.…”